Back
Viridian Therapeutics, Inc. Stock Predictions
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
47
VRDN
Viridian Therapeutics, Inc.
Last Price:
$28.33
Seasonality Move:
-16.34%
7 Day Trial
ALL ACCESS PASS
$
7
Viridian Therapeutics, Inc. Stock Forecast
-
Over the next 52 weeks, Viridian Therapeutics, Inc. has on average historically fallen by 4.2% based on the past 11 years of stock performance.
-
Viridian Therapeutics, Inc. has fallen lower in 6 of those 11 years over the subsequent 52-week period, corresponding to a historical accuracy of 54.55%
-
Is Viridian Therapeutics, Inc. Stock Undervalued?The current Viridian Therapeutics, Inc. [VRDN] share price is $28.89. The Score for VRDN is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
-
VRDN is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will Viridian Therapeutics, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Viridian Therapeutics, Inc. has on average historically fallen by 4.2% based on the past 11 years of stock performance.
Viridian Therapeutics, Inc. Stock Rating
Sell
47
Viridian Therapeutics, Inc. (VRDN)
is a Sell
Is Viridian Therapeutics, Inc. overpriced?
-
Viridian Therapeutics, Inc. has fallen lower in 6 of those 11 years over the subsequent 52-week period, corresponding to a historical accuracy of 54.55%
Viridian Therapeutics, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
viridiantherapeutics.com
52-Week Data
52-Week High:
34.29
52-Week Low:
9.90
Prediction Charts
Market Cap:
3B
Price in USD:
28.89
Volume:
1.4M
Beta:
1.25
Technical Analysis
SMA50:
30.89
SMA100:
29.28
SMA200:
23.26
52-Wk Change:
89.07%
Stock Predictions
-
Is Viridian Therapeutics, Inc. stock public?Yes, Viridian Therapeutics, Inc. is a publicly traded company.
-
What is the Viridian Therapeutics, Inc. stock quote today?The Viridian Therapeutics, Inc. stock price is 28.89 USD today.
-
How to buy Viridian Therapeutics, Inc. stock online?You can buy Viridian Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Feb-13 | 28.77 | 27.90 | 29.41 | 27.80 |
| Feb-17 | 27.90 | 28.29 | 28.39 | 27.45 |
| Feb-18 | 28.55 | 28.11 | 29.03 | 28.02 |
| Feb-19 | 28.01 | 28.10 | 28.60 | 27.41 |
| Feb-20 | 28.19 | 27.44 | 28.30 | 27.20 |
| Feb-23 | 27.32 | 28.07 | 28.45 | 27.26 |
| Feb-24 | 27.99 | 29.40 | 29.88 | 27.99 |
| Feb-25 | 29.57 | 28.94 | 30.33 | 28.76 |
| Feb-26 | 27.05 | 29.49 | 29.58 | 26.31 |
| Feb-27 | 29.01 | 29.38 | 29.75 | 28.20 |
| Mar-2 | 28.75 | 30.25 | 30.45 | 28.20 |
| Mar-3 | 29.43 | 29.32 | 29.60 | 28.42 |
| Mar-4 | 29.45 | 30.39 | 30.69 | 28.68 |
| Mar-5 | 30.34 | 28.89 | 30.79 | 28.54 |
Viridian Therapeutics, Inc. Earnings
Viridian Therapeutics, Inc. Earnings Report: Per Share Viridian Therapeutics, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Viridian Therapeutics, Inc. Forecast Revenue Growth
Viridian Therapeutics, Inc. Stock Analysis: Historical quarterly revenues per share for Viridian Therapeutics, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $0.06 per share, an increase next quarter of $0.13 per share, a decrease this year of $0.26 per share, and an increase next year of $1.63 per share.
* Viridian Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.